Suvretta Capital Management 13F holdings, Q3 2021
Holdings as of September 30, 2021 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 105 US equity positions worth $5.9bn in its Q3 2021 13F filing. The largest position was ADBE at 6.2% of the reported book, followed by AMZN and UNH. Against the Q2 2021 filing, it opened 7 new positions, added to 32 and reduced 6 among the top 50 holdings.
What did Suvretta Capital Management own in Q3 2021? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2021 |
|---|---|---|---|---|---|---|---|
| 1 | ADBE ADOBE SYSTEMS INCORPORATED | Technology | 6.2% | $365.4m | 634,613 | -0% | held |
| 2 | AMZN AMAZON COM INC | Consumer Cyclical | 5.5% | $325.7m | 99,137 | -5% | reduced |
| 3 | UNH UNITEDHEALTH GROUP INC | Healthcare | 4.8% | $279.4m | 715,113 | 3% | added |
| 4 | MA MASTERCARD INCORPORATED | Financial Services | 4.0% | $234.5m | 674,400 | 24% | added |
| 5 | RH RH | Consumer Cyclical | 3.8% | $223.4m | 334,951 | 10% | added |
| 6 | OTIS OTIS WORLDWIDE CORP | Industrials | 3.8% | $222.1m | 2,699,539 | 3% | added |
| 7 | TPR TAPESTRY INC | Consumer Cyclical | 3.4% | $199.1m | 5,378,032 | 4% | added |
| 8 | OPEN OPENDOOR TECHNOLOGIES INC | Real Estate | 3.3% | $193.9m | 9,446,879 | 41% | added |
| 9 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 3.2% | $186.1m | 325,810 | – | new |
| 10 | GFL GFL ENVIRONMENTAL INC | Industrials | 3.0% | $175.2m | 4,715,117 | -2% | reduced |
| 11 | IQV IQVIA HLDGS INC | Healthcare | 2.9% | $168.4m | 703,187 | 18% | added |
| 12 | TWLO TWILIO INC | Technology | 2.8% | $164.8m | 516,520 | 64% | added |
| 13 | UNP UNION PAC CORP | Industrials | 2.7% | $160.7m | 819,697 | -14% | reduced |
| 14 | PWR QUANTA SVCS INC | Industrials | 2.7% | $158.1m | 1,388,834 | 9% | added |
| 15 | EL LAUDER ESTEE COS INC | Consumer Defensive | 2.6% | $154.0m | 513,414 | -0% | held |
| 16 | COR AMERISOURCEBERGEN CORP | Healthcare | 2.5% | $147.5m | 1,234,845 | 5% | added |
| 17 | CVNA CARVANA CO | Consumer Cyclical | 2.5% | $144.5m | 479,143 | -0% | held |
| 18 | ANAPLAN INC | 2.2% | $131.8m | 2,165,238 | 8% | added | |
| 19 | ROST ROSS STORES INC | Consumer Cyclical | 2.1% | $121.7m | 1,117,935 | -0% | held |
| 20 | CPRT COPART INC | Industrials | 2.1% | $121.1m | 872,764 | 5% | added |
| 21 | KBR KBR INC | Industrials | 2.0% | $117.5m | 2,983,377 | -4% | reduced |
| 22 | MDT MEDTRONIC PLC | Healthcare | 1.9% | $114.2m | 911,226 | -30% | reduced |
| 23 | CANO HEALTH INC | 1.8% | $106.8m | 8,419,011 | 18% | added | |
| 24 | PTON PELOTON INTERACTIVE INC | Consumer Cyclical | 1.7% | $101.6m | 1,166,800 | 59% | added |
| 25 | ALIGHT INC | 1.6% | $95.9m | 8,350,000 | – | new | |
| 26 | NTRA NATERA INC | Healthcare | 1.4% | $83.3m | 747,220 | 111% | added |
| 27 | TEL TE CONNECTIVITY LTD | Technology | 1.4% | $82.9m | 603,877 | -0% | held |
| 28 | ADI ANALOG DEVICES INC | Technology | 1.4% | $80.0m | 477,645 | 53% | added |
| 29 | HWM HOWMET AEROSPACE INC | Industrials | 1.4% | $79.6m | 2,551,230 | 54% | added |
| 30 | XYZ SQUARE INC | Technology | 1.2% | $72.7m | 302,930 | – | new |
| 31 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.0% | $60.5m | 1,311,748 | 33% | added |
| 32 | RPRX ROYALTY PHARMA PLC | Healthcare | 0.9% | $55.2m | 1,527,900 | 109% | added |
| 33 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.9% | $54.8m | 1,941,969 | 19% | added |
| 34 | WRBY WARBY PARKER INC | Healthcare | 0.9% | $53.0m | 1,000,000 | – | new |
| 35 | NXPI NXP SEMICONDUCTORS N V | Technology | 0.9% | $50.2m | 256,438 | -37% | reduced |
| 36 | INTRA-CELLULAR THERAPIES INC | 0.8% | $46.7m | 1,251,946 | 21% | added | |
| 37 | KURA KURA ONCOLOGY INC | Healthcare | 0.8% | $46.1m | 2,460,202 | 48% | added |
| 38 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.7% | $42.2m | 2,233,695 | 30% | added |
| 39 | ESTC ELASTIC N V | Technology | 0.7% | $40.4m | 271,000 | – | new |
| 40 | MIRATI THERAPEUTICS INC | 0.6% | $33.8m | 191,308 | 29% | added | |
| 41 | ARENA PHARMACEUTICALS INC | 0.5% | $30.2m | 507,088 | – | new | |
| 42 | DECIPHERA PHARMACEUTICALS IN | 0.5% | $29.3m | 862,126 | 32% | added | |
| 43 | INSM INSMED INC | Healthcare | 0.5% | $27.5m | 998,732 | 126% | added |
| 44 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.5% | $26.9m | 1,543,284 | 30% | added | |
| 45 | MARINUS PHARMACEUTICALS INC | 0.4% | $25.0m | 2,197,426 | 20% | added | |
| 46 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.4% | $22.1m | 9,142,067 | 6% | added |
| 47 | FREYR BATTERY | 0.4% | $20.7m | 2,093,710 | – | new | |
| 48 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.3% | $17.8m | 1,704,589 | 24% | added |
| 49 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.3% | $17.7m | 1,158,961 | 95% | added |
| 50 | AEGLEA BIOTHERAPEUTICS INC | 0.3% | $17.2m | 2,157,727 | 3% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.